Autophagy signaling and the cogwheels of cancer

Joëlle Botti1, Mojgan Djavaheri-Mergny, Yannick Pilatte

  • 1INSERM U756, Faculté de Pharmacie, Université Paris-Sud, 92296 Châtenay-Malabry, France.

Autophagy
|July 29, 2006
PubMed

Insights

Macroautophagy, a cellular process, acts as a tumor suppressor by inhibiting cancer progression. However, cancer cells can also utilize macroautophagy for survival, complicating its role in cancer treatment.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Macroautophagy (a cellular degradation process) is often downregulated in cancer cells, correlating with tumor progression.
  • Signaling pathways regulating macroautophagy are intertwined with critical cellular processes like growth, proliferation, survival, and death.
  • Tumor suppressor genes (e.g., PTEN, TSC2, p53) within the mTOR network promote autophagy, while oncoproteins inhibit it.

Purpose of the Study:

  • To investigate the dual role of macroautophagy in cancer, examining its potential as a tumor suppressor mechanism and its exploitation by cancer cells.
  • To explore the relationship between macroautophagy regulation, signaling pathways, and tumorigenesis.
  • To understand how cancer treatments that induce macroautophagy impact cancer cell eradication versus survival.

Main Methods:

  • Review of existing literature on macroautophagy, signaling pathways (e.g., mTOR), tumor suppressor genes, and oncoproteins in cancer.
  • Analysis of findings from studies involving transgenic mice and cancer treatment responses.
  • Correlation analysis between macroautophagy levels, gene expression (tumor suppressors vs. oncoproteins), and tumor progression/treatment outcomes.

Main Results:

  • Downregulation of macroautophagy is linked to tumor progression.
  • Tumor suppressor genes stimulate autophagy, supporting its role as a tumor suppressor mechanism.
  • Haploinsufficiency of tumor suppressor beclin 1 promotes tumorigenesis.
  • Cancer cells can exploit macroautophagy for survival, even under therapeutic pressure.

Conclusions:

  • Macroautophagy functions as a tumor suppressor mechanism, with its downregulation contributing to cancer development.
  • The interplay between signaling pathways and macroautophagy highlights its complex role in cell fate.
  • Cancer cells can adapt to utilize macroautophagy for survival, presenting a challenge for cancer therapies aiming to induce cell death via this pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...